City of Mason Pilots Forward-Thinking Approach to Managing Cardiovascular Disease and Advancing Heart Health Literacy.
The City of Mason and Genetesis, Inc. are again forging new ground in the fight against heart disease, which has remained the leading cause of death in the U.S. for over a century now. The City of Mason expanded its partnership with cardiac imaging startup Genetesis, which launched its new CardioFlux Membership program on Dec. 11, by becoming its first commercial client.